Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1999 3
2000 1
2001 1
2003 3
2004 2
2005 5
2006 2
2007 6
2008 5
2009 6
2010 3
2011 6
2012 7
2013 12
2014 6
2015 8
2016 9
2017 9
2018 12
2019 18
2020 12
2021 6
2022 6
2023 2
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
Over-irradiation.
Poortmans PMP, Arenas M, Livi L. Poortmans PMP, et al. Breast. 2017 Feb;31:295-302. doi: 10.1016/j.breast.2016.07.022. Epub 2016 Aug 10. Breast. 2017. PMID: 27522160 Review.
Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis.
Lee SF, Kennedy SKF, Caini S, Wong HCY, Yip PL, Poortmans PM, Meattini I, Kaidar-Person O, Recht A, Hijal T, Torres MA, Cao JQ, Corbin KS, Choi JI, Koh WY, Kwan JYY, Karam I, Chan AW, Chow E, Marta GN. Lee SF, et al. Among authors: poortmans pm. BMJ. 2024 Sep 11;386:e079089. doi: 10.1136/bmj-2023-079089. BMJ. 2024. PMID: 39260879 Free PMC article.
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.
Poortmans PM, Weltens C, Fortpied C, Kirkove C, Peignaux-Casasnovas K, Budach V, van der Leij F, Vonk E, Weidner N, Rivera S, van Tienhoven G, Fourquet A, Noel G, Valli M, Guckenberger M, Koiter E, Racadot S, Abdah-Bortnyak R, Van Limbergen EF, Engelen A, De Brouwer P, Struikmans H, Bartelink H; European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups. Poortmans PM, et al. Lancet Oncol. 2020 Dec;21(12):1602-1610. doi: 10.1016/S1470-2045(20)30472-1. Epub 2020 Nov 2. Lancet Oncol. 2020. PMID: 33152277 Clinical Trial.
De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry study.
de Wild SR, de Munck L, Simons JM, Verloop J, van Dalen T, Elkhuizen PHM, Houben RMA, van Leeuwen AE, Linn SC, Pijnappel RM, Poortmans PMP, Strobbe LJA, Wesseling J, Voogd AC, Boersma LJ. de Wild SR, et al. Among authors: poortmans pmp. Lancet Oncol. 2022 Sep;23(9):1201-1210. doi: 10.1016/S1470-2045(22)00482-X. Epub 2022 Aug 8. Lancet Oncol. 2022. PMID: 35952707
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial.
Meattini I, De Santis MC, Visani L, Scorsetti M, Fozza A, Meduri B, De Rose F, Bonzano E, Prisco A, Masiello V, La Rocca E, Spoto R, Becherini C, Blandino G, Moscetti L, Colciago RR, Audisio RA, Brain E, Caini S, Hamaker M, Kaidar-Person O, Lambertini M, Marrazzo L, Saieva C, Spanic T, Strnad V, Wheelwright S, Poortmans PMP, Livi L; EUROPA Trial Investigators. Meattini I, et al. Among authors: poortmans pmp. Lancet Oncol. 2025 Jan;26(1):37-50. doi: 10.1016/S1470-2045(24)00661-2. Epub 2024 Dec 12. Lancet Oncol. 2025. PMID: 39675376 Clinical Trial.
The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies.
Kaidar-Person O, Boersma LJ, De Brouwer P, Weltens C, Kirkove C, Peignaux-Casasnovas K, Budach V, van der Leij F, Peters M, Weidner N, Rivera S, van Tienhoven G, Fourquet A, Noel G, Valli M, Guckenberger M, Koiter E, Racadot S, Abdah-Bortnyak R, Bartelink H, Struikmans H, Fortpied C, Poortmans PM; EORTC Radiation Oncology and Breast Cancer Groups. Kaidar-Person O, et al. Among authors: poortmans pm. Radiother Oncol. 2024 Dec;201:110563. doi: 10.1016/j.radonc.2024.110563. Epub 2024 Sep 26. Radiother Oncol. 2024. PMID: 39341505 Clinical Trial.
Radiation of the Internal Mammary Nodes: Is There a Benefit?
Haffty BG, Whelan T, Poortmans PM. Haffty BG, et al. Among authors: poortmans pm. J Clin Oncol. 2016 Feb 1;34(4):297-9. doi: 10.1200/JCO.2015.64.7552. Epub 2015 Nov 30. J Clin Oncol. 2016. PMID: 26628473 No abstract available.
Is Postoperative Breast Radiation Therapy Safe in Patients With Scleroderma?
Belkacemi Y, Majdoul S, Tsoutsou PP, Abouegylah M, Kaidar-Person O, Meattini I, Poortmans PMP, Taghian A. Belkacemi Y, et al. Among authors: poortmans pmp. Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):10-11. doi: 10.1016/j.ijrobp.2019.02.018. Int J Radiat Oncol Biol Phys. 2019. PMID: 30967221 No abstract available.
De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1-2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07).
de Wild SR, van Roozendaal LM, de Wilt JHW, van Dalen T, van der Hage JA, van Duijnhoven FH, Simons JM, Schipper RJ, de Munck L, van Kuijk SMJ, Boersma LJ, Linn SC, Lobbes MBI, Poortmans PMP, Tjan-Heijnen VCG, van de Vijver KKBT, de Vries J, Westenberg AH, Strobbe LJA, Smidt ML. de Wild SR, et al. Among authors: poortmans pmp. Br J Surg. 2024 Apr 3;111(4):znae077. doi: 10.1093/bjs/znae077. Br J Surg. 2024. PMID: 38597154 Free PMC article.
132 results